Improved quantity and quality of life: a winning combination to treat advanced heart failure.

Rogers et al. ([1][1]) describe in this issue of the Journal the largest report of functional capacity and quality of life to date in patients implanted with a continuous flow left ventricular assist device (LVAD). Patients were implanted for 2 indications: bridge to transplant (BTT) (n = 281) and

[1]  S. Russell,et al.  Continuous flow left ventricular assist device improves functional capacity and quality of life of advanced heart failure patients. , 2010, Journal of the American College of Cardiology.

[2]  S. Russell,et al.  Advanced heart failure treated with continuous-flow left ventricular assist device. , 2009, The New England journal of medicine.

[3]  Robert L Kormos,et al.  Second INTERMACS annual report: more than 1,000 primary left ventricular assist device implants. , 2010, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

[4]  O H Frazier,et al.  Use of a continuous-flow device in patients awaiting heart transplantation. , 2007, The New England journal of medicine.

[5]  M. Shishehbor,et al.  Prognosis on Chronic Dobutamine or Milrinone Infusions for Stage D Heart Failure , 2009, Circulation. Heart failure.

[6]  D. Delurgio,et al.  Cardiac resynchronization in chronic heart failure. , 2002, The New England journal of medicine.

[7]  M C Oz,et al.  Long-term use of a left ventricular assist device for end-stage heart failure. , 2001, The New England journal of medicine.